Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
5.20
-0.02 (-0.38%)
Jun 18, 2026, 4:00 PM EDT - Market closed
MRVI Market Cap
MRVI has a market cap or net worth of $1.34 billion as of June 18, 2026. Its market cap has increased by 138.56% in one year.
Market Cap
1.34B
Enterprise Value
1.49B
1-Year Change
138.56%
Ranking
Category
Stock Price
$5.20
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $7.23B to $1.34B, a decrease of -81.43%. That is a compound annual growth rate of -26.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.34B | 61.56% |
| Dec 31, 2025 | 831.00M | -39.62% |
| Dec 31, 2024 | 1.38B | -16.38% |
| Dec 29, 2023 | 1.65B | -54.93% |
| Dec 30, 2022 | 3.65B | -66.18% |
| Dec 31, 2021 | 10.80B | 49.29% |
| Dec 31, 2020 | 7.23B | 0.01% |
| Nov 20, 2020 | 7.23B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.40B |
| MoonLake Immunotherapeutics | 1.40B |
| GH Research | 1.37B |
| Inhibrx Biosciences | 1.37B |
| Savara | 1.34B |
| Maze Therapeutics | 1.32B |
| Damora Therapeutics | 1.27B |
| Aktis Oncology | 1.25B |